JP2007524096A - 粘膜投与用ワクチンの治療可能性の評価方法 - Google Patents

粘膜投与用ワクチンの治療可能性の評価方法 Download PDF

Info

Publication number
JP2007524096A
JP2007524096A JP2007500050A JP2007500050A JP2007524096A JP 2007524096 A JP2007524096 A JP 2007524096A JP 2007500050 A JP2007500050 A JP 2007500050A JP 2007500050 A JP2007500050 A JP 2007500050A JP 2007524096 A JP2007524096 A JP 2007524096A
Authority
JP
Japan
Prior art keywords
weeks
ige
antibody
complex
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007500050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007524096A5 (fr
Inventor
ハンス ヘンリック イプセン
リーセ ルンドメルケダフル
ヘンリック ヒューゴ ヤコビ
Original Assignee
アルカベロ アクチェセルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルカベロ アクチェセルスカプ filed Critical アルカベロ アクチェセルスカプ
Publication of JP2007524096A publication Critical patent/JP2007524096A/ja
Publication of JP2007524096A5 publication Critical patent/JP2007524096A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
JP2007500050A 2004-02-26 2005-02-24 粘膜投与用ワクチンの治療可能性の評価方法 Pending JP2007524096A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54845404P 2004-02-26 2004-02-26
DKPA200400310 2004-02-26
US55909504P 2004-04-02 2004-04-02
PCT/DK2005/000123 WO2005083385A2 (fr) 2004-02-26 2005-02-24 Procede pour evaluer le potentiel therapeutique d'un vaccin a administration mucosale

Publications (2)

Publication Number Publication Date
JP2007524096A true JP2007524096A (ja) 2007-08-23
JP2007524096A5 JP2007524096A5 (fr) 2008-07-17

Family

ID=34915878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007500050A Pending JP2007524096A (ja) 2004-02-26 2005-02-24 粘膜投与用ワクチンの治療可能性の評価方法

Country Status (8)

Country Link
EP (1) EP1718974A2 (fr)
JP (1) JP2007524096A (fr)
AU (1) AU2005217696B2 (fr)
BR (1) BRPI0508078A (fr)
CA (1) CA2556557A1 (fr)
IL (1) IL177703A0 (fr)
RU (1) RU2006134031A (fr)
WO (1) WO2005083385A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017195871A1 (fr) 2016-05-13 2017-11-16 応用酵素医学研究所株式会社 Procédé permettant de collecter des données pour prédire le risque de développer des allergies

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006134031A (ru) * 2004-02-26 2008-04-10 Альк-Абелло А/С (Dk) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки
AU2008231722B2 (en) * 2007-03-28 2013-09-12 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
ES2370043T3 (es) 2007-03-28 2011-12-12 Alk-Abelló A/S Uso de una formulación de vacuna de la alergia coadyuvada para administración subcutánea.
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519638A (ja) * 1998-06-24 2002-07-02 アルク−アベル・アー／エス 液体試料中における抗体の検出方法
WO2004005925A2 (fr) * 2002-07-05 2004-01-15 Isis Innovation Limited Methode diagnostique
WO2005083385A2 (fr) * 2004-02-26 2005-09-09 Alk-Abelló A/S Procede pour evaluer le potentiel therapeutique d'un vaccin a administration mucosale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508220A (ja) * 1991-05-10 1993-11-18 ドゥ・ウエック、アラン 抗ＩｇＥ自己抗体の検出および調製法およびこれら抗体の診断および治療組成物中での活性剤としての使用
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
AU1960100A (en) * 1999-01-06 2000-07-24 Mcmaster University Method of preventing immune and hypersensitivity reactions
SE0004892D0 (sv) * 2000-12-29 2000-12-29 Pharmacia Diagnostics Ab Group 2 allergen specific IgE-Fabs and use thereof
UA62780A (en) * 2003-05-22 2003-12-15 Univ Oo Bohomolets Nat Medical Method for estimating efficiency of vaccination against diphtheria in children with allergic diathesis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519638A (ja) * 1998-06-24 2002-07-02 アルク−アベル・アー／エス 液体試料中における抗体の検出方法
WO2004005925A2 (fr) * 2002-07-05 2004-01-15 Isis Innovation Limited Methode diagnostique
WO2005083385A2 (fr) * 2004-02-26 2005-09-09 Alk-Abelló A/S Procede pour evaluer le potentiel therapeutique d'un vaccin a administration mucosale

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017195871A1 (fr) 2016-05-13 2017-11-16 応用酵素医学研究所株式会社 Procédé permettant de collecter des données pour prédire le risque de développer des allergies
US11686733B2 (en) 2016-05-13 2023-06-27 Applied Medical Enzyme Research Institute Corporation Method for collecting data to predict risk of developing allergies

Also Published As

Publication number Publication date
EP1718974A2 (fr) 2006-11-08
RU2006134031A (ru) 2008-04-10
WO2005083385A2 (fr) 2005-09-09
AU2005217696A1 (en) 2005-09-09
IL177703A0 (en) 2006-12-31
AU2005217696B2 (en) 2008-02-14
BRPI0508078A (pt) 2007-07-17
WO2005083385A3 (fr) 2005-11-17
CA2556557A1 (fr) 2005-09-09

Similar Documents

Publication Publication Date Title
AU2005304107B2 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
AU2006310881B2 (en) Use of a liquid allergy vaccine formulation for oromucosal administration
US7887821B2 (en) Process for producing an allergen extract
AU2005217696B2 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
EP1793853B1 (fr) Formulation de vaccin liquide contre une allergie pour une administration sur les muqueuses buccales
US20060171968A1 (en) Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
US20060002962A1 (en) Method of treating allergy and infection by eliciting an IGA antibody response
EP1834648B1 (fr) Procédé pour la préparation d'un extrait d'allergène
US20050202030A1 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
MXPA06009737A (es) Metodo para evaluar el potencial terapeutico de una vacuna de administracion por la mucosa
US20100291155A1 (en) Allergy vaccine composition for mucosal administration
US7867715B2 (en) Method of evaluating the immunological activity of a vaccine
US20220196675A1 (en) Method for classifying an allergic patient as eligible to allergen immunotherapy
PT1812059E (pt) MéTODO DE TRATAMENTO PREVENTIVO DA ALERGIA POR ADMINISTRAÆO POR VIA MUCOSAL DE UMA VACINA PARA A ALERGIA
ZA200702413B (en) Liquid allergy vaccine formulation for oromucosal administration

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100419

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100921